Dental management of patients taking antiplatelet, oral anticoagulant and novel anticoagulant medications

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Anticoagulant and antiplatelet medications.

CRITICALCARENURSE Vol 26, No. 3, JUNE 2006 19 2. Paradiso-Hardy FL, Madan M, Radhakrishnan S, Hurden S, Cohen EA. Severe thrombocytopenia possibly related to readministration of eptifibatide. Catheter Cardiovasc Interv. September 2001;54:63-67. 3. Hongo RH, Brent BN. Association of eptifibatide and acute profound thrombocytopenia. Am J Cardiol. 2001;88:428-431. 4. Yoder M, Edwards RF. Reversibl...

متن کامل

Dental management of patients receiving anticoagulant and/or antiplatelet treatment

INTRODUCTION Adequate hemostasis is crucial for the success of invasive dental treatment, since bleeding problems can give rise to complications associated with important morbidity-mortality. The dental treatment of patients who tend to an increased risk of bleeding due to the use of anticoagulant and/or antiplatelet drugs raises a challenge in the daily practice of dental professionals. Adequa...

متن کامل

A surgeon’s guide to anticoagulant and antiplatelet medications part one: warfarin and new direct oral anticoagulant medications

Departments of Surgery and Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada Department of Surgery, Dignity Health/St. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USA Center for Trauma and Critical Care, George Washington University, Washington DC, USA Kaiser Permanente, Los Angeles, California, USA Division of Trauma and Surgical Critical Care, Department of S...

متن کامل

A Study of the Management of Patients Taking Novel Oral Antiplatelet or Direct Oral Anticoagulant Medication Undergoing Dental Surgery in a Rural Setting

PURPOSE Novel oral antiplatelet (NOAP) (prasugrel and ticagrelor) and direct oral anticoagulant drugs (DOAC) (dabigatran, rivaroxaban and apixaban) have emerged in the last decade. This study was undertaken to determine current approaches taken to the management of patients taking these agents in dental practice in a remote and rural setting. METHODS A small retrospective study was carried ou...

متن کامل

New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents.

BACKGROUND The strategy of whether to continue anticoagulation and antiplatelet agents during surgery depends on an evaluation of the thromboembolic risk and haemorrhagic risk of the individual patients. Procedures that carry a significant risk of bleeding may require temporary cessation of the medication. OBJECTIVE We briefly review the use of common oral anticoagulant and antiplatelet agent...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Military Medical and Pharmaceutical Journal of Serbia

سال: 2019

ISSN: 0042-8450,2406-0720

DOI: 10.2298/vsp170719128b